The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA This session will provide insight into the novel microbiome driven strategies to treat GI disorders. The talks in the session encompass the role of short-chain fatty acids and probiotics in disorders of GI motility and aging, the protective effects of Saccharomyces boulardii in colitis-associated colorectal cancer, and utility of fecal microbiota transplantation in inflammatory GI disorders.
TUMOR PROMOTING ROLE OF EPIPLOIC ADIPOSE TISSUE IN COLON OF OBESE INDIVIDUALS IS MEDIATED VIA LIPID DROPLETS ASSOCIATED ADIPOSE TRIGLYCERIDE LIPASE (ATGL)
SOCIETY: AGA This session will focus on novel findings linking specific microbial species and their metabolites with tumorigenesis specifically colon cancer, tumor microenvironment and immune responses…